MARKET

SEPN

SEPN

Septerna, Inc.
NASDAQ
26.34
-0.36
-1.35%
Closed 16:32 02/11 EST
OPEN
26.97
PREV CLOSE
26.70
HIGH
26.97
LOW
25.36
VOLUME
233.63K
TURNOVER
--
52 WEEK HIGH
30.50
52 WEEK LOW
4.170
MARKET CAP
1.18B
P/E (TTM)
-17.4796
1D
5D
1M
3M
1Y
5Y
1D
Septerna Grants Stock Options to New Chief Legal Officer Under 2026 Inducement Plan
Reuters · 1d ago
Septerna Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Barchart · 1d ago
Septerna to Present Phase 1 Trial Data for SEP-631 in Mast Cell Diseases at 2026 AAAAI Meeting
Reuters · 2d ago
Weekly Report: what happened at SEPN last week (0202-0206)?
Weekly Report · 3d ago
Peakstone Realty Trust, Aquestive Therapeutics, Opera And Other Big Stocks Moving Higher On Monday
Benzinga · 02/02 15:44
Weekly Report: what happened at SEPN last week (0126-0130)?
Weekly Report · 02/02 09:45
Weekly Report: what happened at SEPN last week (0119-0123)?
Weekly Report · 01/26 09:45
MRNA is S&P 500’s top performing stock, here are the best Quant pharma companies
Seeking Alpha · 01/21 19:36
More
About SEPN
Septerna, Inc. is a clinical-stage biotechnology company. The Company is developing G protein-coupled receptor (GPCR) oral small-molecule drug discovery powered by its proprietary Native Complex Platform. Its pipeline of product candidates is focused on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic diseases. Its industrial-scale Native Complex Platform is designed to target certain GPCRs for the first time, uncover novel binding pockets for validated receptors, and pursue a wide spectrum of pharmacologies, including agonists, antagonists, and allosteric modulators, to achieve desired therapeutic effects. It is advancing a deep portfolio of oral small molecule GPCR-targeted programs with novel mechanistic approaches to treat diseases across multiple therapeutic areas for patients with unmet needs. It is focused on therapeutic areas, such as neurology, women’s health, cardiovascular, and respiratory disease.

Webull offers Septerna, Inc. stock information, including NASDAQ: SEPN real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, SEPN stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading SEPN stock methods without spending real money on the virtual paper trading platform.